Brind.

HSIC's Price-to-Earnings ratio was reported to be lower than the industry average on June 30, 2025.

1 report, 0 independent Updated Jun 30

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

SpeculativeNo independent reporting found

Who's involved

What this event is mainly about

Incepta Pharmaceuticals Henry Schein

Keep exploring

The entities involved

Incepta Pharmaceuticals
incepta
- Tilray Brands, Inc.'s stock change lagged the S&P 500 gain on August 28, 2025, while the company holds a Zacks Rank of #3.Sun 03:24
- Precision BioSciences and Incepta Pharmaceuticals were noted as belonging to a specified industry in August 2025.Sat 20:39
Henry Schein
American distributor of health care products and services
- Tony Ream-Hendley faces civil judgment and sentencing in New York after allegedly stealing $1.6 million from Henry Schein regarding a restaurant project.Mon 13:27
- Dental equipment industry competition involving Dentsply Sirona, Align Technology, Nobel Biocare, and Henry Schein.Thu 13:21

Coverage

Newest first; wire copies grouped

Jun 30Unknown outlet